BRENNEN

Industries / Health / Pharmaceuticals

Quality and records

Checking that each batch was made as written, and keeping records that prove it.

6

Milestones achieved, from 1910 to 2026.

1

To watch for: announced, not yet confirmed outside.

2

Open deliverables. Nobody has shipped them.

The road

AchievedWatch forOpen

Achieved

  1. 1910

    Tested before it shipped

    Ehrlich offered Salvarsan to the many doctors who asked for it only after quality controls and further tests in his laboratory, and his team developed tests for whether the drug had oxidised.

    jameslindlibrary.org

    Credit

    Paul Ehrlich's laboratory

  2. 1997

    Electronic records accepted

    The FDA's Part 11 rule, issued in March 1997 and in effect from 20 August 1997, set the conditions under which electronic records and electronic signatures count as equal to paper records and handwritten signatures.

    fda.gov

    Credit

    FDA

  3. 2008

    A contaminant in heparin

    US investigators led by the Centers for Disease Control and Prevention linked 152 adverse reactions in 113 patients in 13 states, between November 2007 and January 2008, to the blood thinner heparin made by Baxter. Vials held a contaminant, oversulfated chondroitin sulfate. A second team showed how it could cause the reactions and proposed an extra test to add to the existing checks.

    LessonA test finds only what it was designed to look for.

    europepmc.orgeuropepmc.org

    Credit

    D. B. Blossom and colleagues (CDC investigation); T. K. Kishimoto and colleagues

  4. 2013

    Falsified data, criminal plea

    The generic drug maker Ranbaxy pleaded guilty to three felony charges, including lying to the FDA, and agreed to pay $500 million in penalties, the US Department of Justice announced on 13 May 2013.

    LessonManufacturing and test records are legal evidence, and false ones are a crime.

    raps.org

    Credit

    US Department of Justice; FDA

  5. 2018

    An impurity from a process

    On 13 July 2018 the FDA announced a recall of medicines containing valsartan, a blood-pressure drug, after NDMA, a probable human carcinogen, was found in active ingredient from a third-party supplier. The FDA said the impurity "was unexpected and is thought to be related to changes in the way the active substance was manufactured".

    LessonA change in how an ingredient is made can create impurities that existing tests do not look for.

    biopharminternational.comfda.gov

    Credit

    FDA

  6. 2026

    AI-drafted records draw a warning

    The FDA sent a warning letter to Purolea Cosmetics Lab of Livonia, Michigan, which said it had used AI to produce drug product specifications, procedures and master control records. The FDA cited 21 CFR 211.22(c), the rule on the duties of a company's quality control unit.

    LessonAI can draft a GMP record, but the company's quality unit still answers for it.

    raps.org

    Credit

    FDA; reported by RAPS on 17 April 2026

Watch for

  1. AI review of batch records

    Enveda built CDP, a reviewer of executed batch records (the filled-in copy of a batch's written instructions) based on Claude. On four records from one manufacturing campaign, 1,061 scanned and mostly handwritten pages, it raised all 11 issues that human reviewers had found, counted across several runs. Anthropic reports that it also flagged 7 issues the humans had missed and cut review time by 89%, from over 25 hours to under 3.

    Achieved whena party outside both companies runs the method on other records, from another product or site, and publishes the scores. The note "Seven more flagged" (Claude at Enveda) examines how the two counts were gathered.

    enveda.comanthropic.com

    Claimed by

    Enveda and Anthropic, October 2026

Open

  1. 01

    A public batch-record answer key

    A set of realistic but fictional executed batch records for a made-up product, scanned, handwritten, with crossed-out corrections and with errors placed on purpose. Publish the answer key so that any review tool, human or machine, can be scored.

    The brief
    Credit · unclaimed
  2. 02

    Test AI-drafted master records

    A public test in which several AI systems draft master production records, the written instructions for making a batch, from fictional product briefs. Two reviewers with GMP experience score each draft against the items US rules require, such as the product's name and strength and a complete list of components. The drafts are never used to make anything.

    The brief
    Credit · unclaimed

Open 01 · the brief

A public batch-record answer key

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A set of realistic but fictional executed batch records for a made-up product, scanned, handwritten, with crossed-out corrections and with errors placed on purpose. Publish the answer key so that any review tool, human or machine, can be scored.

Why it is still open

The best-documented test so far used Enveda's own records, which Enveda says "cannot be made public" because they hold proprietary and personal data. No one outside can rerun it.

enveda.com

Built with what exists

Enveda's open-source companion code, open-doc-review (MIT licence); a word processor for the master batch record; volunteers to fill pages by hand; a scanner; Claude, Gemini and open-weight models to test. The advance is language models that read scanned handwriting a page at a time; the note "Seven more flagged" covers one.

  1. First step

    Write a two-page master batch record for a fictional placebo tablet, then fill 20 pages by hand with 10 seeded errors.

  2. Done looks like

    At least 500 pages holding at least 100 seeded errors in stated classes, an answer key checked by two people, and at least three review tools scored on how many errors they catch and how many false alarms they raise, all published.

Open 02 · the brief

Test AI-drafted master records

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A public test in which several AI systems draft master production records, the written instructions for making a batch, from fictional product briefs. Two reviewers with GMP experience score each draft against the items US rules require, such as the product's name and strength and a complete list of components. The drafts are never used to make anything.

Why it is still open

The FDA's 2026 warning letter shows a company using AI to write such records. I found no public measure of how often AI drafts leave out required items.

raps.orglaw.cornell.edu

Built with what exists

the text of 21 CFR 211.186, turned into a checklist; Claude, Gemini, GPT and an open-weight model; a spreadsheet for scores.

  1. First step

    Turn the list in 21 CFR 211.186(b) into a checklist and score five drafts.

  2. Done looks like

    30 briefs, 4 systems and 120 drafts, each scored by two reviewers, with the miss rate for each required item and the agreement between reviewers published.